In the biopharmaceutical realm, the harsh reality is a staggering 95% failure rate in human clinical trials, despite promising results in animal testing. However, a rising star in the industry, Vivodyne, is poised to confront this formidable challenge head-on, armed with $40 million in Series A financing and a revolutionary approach to preclinical testing. Vivodyne […]
Category: Vivodyne
Vivodyne’s $40 Million Raise to Bypass Animal Models
In a seismic shift that could herald a new era in preclinical drug testing, Philadelphia-based biotech startup Vivodyne has secured $40 million in Series A funding. The funds are set to propel the development of its groundbreaking robotic, AI-enabled platform, which is designed to test drug candidates on lab-grown human tissues. This ambitious endeavor sidesteps […]
